Bank of America
MRKR icon

Bank of America’s Marker Therapeutics MRKR Stock Holding History

Bank of America’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,126
Closed -$1.68K – 6456
2025
Q4 		$1.68K Buy
1,126
+3
+0.3% +$3 ﹤0.01% 6424
2025
Q3 		$1K Buy
1,123
+9
+0.8% +$11 ﹤0.01% 7495
2025
Q2 		$1.7K Sell
1,114
-2,117
-66% -$2.72K ﹤0.01% 7455
2025
Q1 		$3.97K Buy
3,231
+13
+0.4% +$24 ﹤0.01% 7252
2024
Q4 		$10K Buy
3,218
+601
+23% +$2.13K ﹤0.01% 6979
2024
Q3 		$7.38K Buy
2,617
+1
+0% +$4 ﹤0.01% 6948
2024
Q2 		$14.2K Buy
2,616
+54
+2% +$229 ﹤0.01% 6820
2024
Q1 		$11K Buy
2,562
+228
+10% +$996 ﹤0.01% 6864
2023
Q4 		$12.8K Sell
2,334
-886
-28% -$3K ﹤0.01% 6876
2023
Q3 		$14.6K Sell
3,220
-824
-20% -$4.61K ﹤0.01% 6779
2023
Q2 		$12.5K Sell
4,044
-625
-13% -$1.09K ﹤0.01% 6811
2023
Q1 		$3.31K Buy
4,669
+4,158
+814% +$9.89K ﹤0.01% 7144
2022
Q4 		$1.35K Buy
511
+11
+2% +$38 ﹤0.01% 7297
2022
Q3 		$1K Hold
500
– – ﹤0.01% 7678
2022
Q2 		$1K Hold
500
– – ﹤0.01% 7876
2022
Q1 		$2K Buy
500
+140
+39% +$800 ﹤0.01% 8048
2021
Q4 		$4K Sell
360
-721
-67% -$9.58K ﹤0.01% 7885
2021
Q3 		$18K Sell
1,081
-985
-48% -$20.2K ﹤0.01% 7422
2021
Q2 		$58K Sell
2,066
-3,765
-65% -$99.1K ﹤0.01% 6763
2021
Q1 		$131K Buy
5,831
+3,203
+122% +$73.3K ﹤0.01% 6280
2020
Q4 		$37K Buy
2,628
+549
+26% +$8.52K ﹤0.01% 6430
2020
Q3 		$32K Sell
2,079
-73
-3% -$1.33K ﹤0.01% 6172
2020
Q2 		$45K Buy
2,152
+1,054
+96% +$23K ﹤0.01% 6027
2020
Q1 		$21K Sell
1,098
-261
-19% -$6.65K ﹤0.01% 6161
2019
Q4 		$39K Sell
1,359
-109
-7% -$3.96K ﹤0.01% 6325
2019
Q3 		$75K Buy
1,468
+929
+172% +$54.9K ﹤0.01% 6176
2019
Q2 		$43K Sell
539
-529
-50% -$31.4K ﹤0.01% 6366
2019
Q1 		$71K Buy
+1,068
New +$62.4K ﹤0.01% 6045
2018
Q4 		– Sell
-20
Closed -$2K – 7270
2018
Q3 		$2K Buy
20
+19
+1,900% +$1.63K ﹤0.01% 7025
2018
Q2 		$0 Hold
1
– – ﹤0.01% 7231
2018
Q1 		$0 Buy
+1
New +$35 ﹤0.01% 7247
2017
Q4 		– Sell
-7
Closed – – 7165
2017
Q3 		$0 Buy
+7
New +$221 ﹤0.01% 7186

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Bank of America's MRKR Position: Q1 2026 in Review

Bank of America sold out of Marker Therapeutics (MRKR) in Q1 2026, closing a stake of 1,126 shares — an estimated $1.68K sold.

Bank of America first reported a position in MRKR in Q3 2017 and held it in 32 quarters. The position peaked at $131K in Q1 2021. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

  • Bank of America reported no remaining Marker Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1,126 Marker Therapeutics shares in Q1 2026, an estimated $1.68K.
  • Bank of America first reported a position in Marker Therapeutics in Q3 2017 and held it in 32 quarters.
  • Bank of America's Marker Therapeutics position peaked at $131K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.